| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Prepaid expenses | - | 35,000 | ||
| Cash | 4,323 | 26 | ||
| Security deposit | 0 | 4,600 | ||
| Total current assets | 4,323 | 39,626 | ||
| Operating lease right of use asset | 0 | 13,651 | ||
| Total assets | 4,323 | 53,277 | ||
| Accounts payable and accrued expenses | 116,582 | 95,493 | ||
| Deferred revenue | 20,000 | 20,000 | ||
| Due to related parties | 300,360 | 241,653 | ||
| Operating lease liabilities - current | 0 | 13,651 | ||
| Total current and total liabilities | 436,942 | 370,797 | ||
| Common stock 100,000,000 authorized 0.001 par value 60,042,000 shares issued and outstanding | 60,042 | 60,042 | ||
| Additional paid-in capital | 32,308,806 | 32,306,096 | ||
| Accumulated deficit | -32,801,467 | -32,683,658 | ||
| Total stockholders' deficit | -432,619 | -317,520 | ||
| Total liabilities and stockholders' deficit | 4,323 | 53,277 | ||
ACRO BIOMEDICAL CO., LTD. (ACBM)
ACRO BIOMEDICAL CO., LTD. (ACBM)